THE USE OF THE MURINE CHRONIC GRAFT VS HOST (CGVH) DISEASE, A MODEL FOR SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), FOR DRUG DISCOVERY

被引:39
作者
POPOVIC, S [1 ]
BARTLETT, RR [1 ]
机构
[1] HOECHST AG,DEPT PHARMACOL,D-6200 WIESBADEN 12,FED REP GER
来源
AGENTS AND ACTIONS | 1987年 / 21卷 / 3-4期
关键词
D O I
10.1007/BF01966492
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:284 / 286
页数:3
相关论文
共 4 条
[1]   IMMUNOPHARMACOLOGICAL PROFILE OF A NOVEL ISOXAZOL DERIVATIVE, HWA-486, WITH POTENTIAL ANTIRHEUMATIC ACTIVITY .1. DISEASE MODIFYING ACTION ON ADJUVANT ARTHRITIS OF THE RAT [J].
BARTLETT, RR ;
SCHLEYERBACH, R .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (01) :7-+
[2]   IMMUNOPHARMACOLOGICAL PROFILE OF HWA-486, A NOVEL ISOXAZOL DERIVATIVE .2. INVIVO IMMUNOMODULATING EFFECTS DIFFER FROM THOSE OF CYCLOPHOSPHAMIDE, PREDNISOLONE, OR CYCLOSPORINE-A [J].
BARTLETT, RR .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1986, 8 (02) :199-204
[3]   A SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)-LIKE DISEASE IN MICE INDUCED BY ABNORMAL T-B-CELL COOPERATION - PREFERENTIAL FORMATION OF AUTOANTIBODIES CHARACTERISTIC OF SLE [J].
GLEICHMANN, E ;
VANELVEN, EH ;
VANDERVEEN, JPW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1982, 12 (02) :152-159
[4]  
VANELVEN EH, 1981, J IMMUNOL, V126, P1684